FcgammaRIIIA and FcgammaRIIA polymorphisms do not predict clinical outcome of follicular non-Hodgkin's lymphoma patients treated with sequential CHOP and rituximab.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples